Mayne Pharma Group Limited [ASX:MYX] share price and news 2022

Company Description

Mayne Pharma Group Limited (MYX) is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialize branded and generic pharmaceuticals. Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide.

Mayne Pharma Group Limited belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website: http://www.maynepharma.com.

This a small cap company with market cap of 562 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is greater than both sector and market. while Company PB is less than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0.99 55.5 0.54 0
Market 1.03 20.6 1.71 1.15
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how myx dividend grows in the recent years.